Baijin Life Science Holdings has the GF Score of 36, which implies that the company
might have
Worst future performance potential, or not enough data.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes Baijin Life Science Holdings
might have
Worst future performance potential, or not enough data.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Baijin Life Science Holdings (OTCPK:MNNGF) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Baijin Life Science Holdings GF Score Related Terms
MNNGF vs TPR: GF Score Comparison
For the Luxury Goods subindustry, Baijin Life Science Holdings's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baijin Life Science Holdings GF Score vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's GF Score distribution charts can be found below:
* The bar in red indicates where Baijin Life Science Holdings's GF Score falls into.
Baijin Life Science Holdings (MNNGF) has a GF Score of 36 as of Jul. 03, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Baijin Life Science Holdings and its competitors. This is near median its historical median of 33.00. Over the past decade, Baijin Life Science Holdings' GF Score has ranged from 11.00 to 47.00.
Is Baijin Life Science Holdings' GF Score too high?
Baijin Life Science Holdings' current GF Score of 36 is near median its 10-year median of 33.00. Over the past 10 years, this metric has ranged from a low of 11.00 to a high of 47.00. Overall, Baijin Life Science Holdings has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Baijin Life Science Holdings' GF Score compare to TPR?
Baijin Life Science Holdings' GF Score of 36 can be compared against companies in the Retail - Cyclical industry. Historically, Baijin Life Science Holdings' own GF Score has ranged from 11.00 to 47.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Retail - Cyclical company?
A good GF Score depends on the Retail - Cyclical industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Baijin Life Science Holdings and its competitors. Baijin Life Science Holdings's current GF Score is 36, which is near median its own 10-year median of 33.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baijin Life Science Holdings stock overvalued right now?
Baijin Life Science Holdings (MNNGF) has a current GF Score of 36. The stock's GF Value™ is $0.06, compared to a current price of $0.08 — trading 25% above its estimated fair value. The current GF Score is 36, which is near median its 10-year median of 33.00. Baijin Life Science Holdings' overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Baijin Life Science Holdings (MNNGF), the current GF Score is 36 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Baijin Life Science Holdings (MNNGF) Overvalued in 2026?
Based on GuruFocus' analysis, Baijin Life Science Holdings stock appears to be overvalued.
The current stock price of $0.08 is trading 25% above its estimated GF Value™ of $0.06.
Key valuation signals for MNNGF:
GF Score: 36 (near median its 10-year median of 33.00)
GF Value™: $0.06 vs. price of $0.08 (25% above fair value)
No single metric tells the full story. See the MNNGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
36GF Score
Get the complete analysis for MNNGF
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MNNGF has been successfully added to your 